Medalogix is getting attention for helping care providers best leverage analytics to improvelives. Harvard is one such prestigious organization who has taken notice.
A former home health agency owner, our CEODan Hogandecided touse clinical data to understandwhich of his patients were most likely to be readmitted to the hospital. He did this so he could intervene and stop readmissions in their tracks. Lo and behold—the data analysisworked.
Years and many innovations later, Dan’s healthcare technology solutionsare still leveraging data insightsto improve care and reduce costs. One of the most notable solutions is Medalogix Bridge, our end-of-life analytics technology. It helps caregivers understand which home health patients aremost likely to benefit from hospice care.
After being a finalist in Harvard’s Healthcare Innovation Challenge, Dan was invited to speakabout end-of-life care and analyticsatHarvard’s Forum on Healthcare Innovation.
This Forum is a collaboration betweenHarvard Business School(HBS) andHarvard Medical School(HMS). Its purpose is to unite leading executives, policymakers, and academics in a cross-disciplinary exploration of innovative actions to improve quality, reduce costs, and, ultimately, increase value in the health care industry.
Medalogix is excited and honored to be one of these great finalists. Learn more about what this means for ushere, and, take 3 minutes to watch Dan’s presentation below orhere. It’sa great nutshell of what Medalogix is accomplishing.
Besides a potential $2 Billion in savings in the market, the real impact of the work that we’re doing is getting the right people tothe right care venue at the right time. In a hospice scenario this is imperative, as the earlier identified hospice-appropriate patients have more timeto make the best decision for themselves and their families.
To see the end-of-life analytics technology referenced in Dan’s message, schedule a 15-min demo.